AAV-hTERT

N/A

Report date: 2024/11/20 20:00:31

Base Information

Drug NameAAV-hTERT
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionTERT gene transference
TargetsTelomerase reverse transcriptase
Therapy Area/IndicationsHealthy AgingAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryColombia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLibella Gene Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLibella Gene Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsHealthy AgingAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A